MedTrace Logo

Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement

NCT05718908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-02-10

No results posted yet for this study

Summary

Fibromyalgia is a syndrome (set of symptoms) of unknown etiology and characterized by diffuse musculoskeletal pain and chronic fatigue. In addition, other symptoms such as cognitive alterations, sleep rhythm disturbances, psychiatric syndromes such as anxiety, depression, etc. Other very characteristic symptoms are hyperalgesia (very low pain threshold) and allodynia (amplified response to painful stimuli).

The treatment of fibromyalgia is symptomatic and the drugs only serve to reduce symptoms in some patients, in addition to the fact that these available treatments (antidepressants, pain signal modulators, rescue analgesics, etc.) have many side effects.

The food supplement which is the object of this study, FibrofixPlus®, is made up of a combination of natural substances.

This is the reason why this observational study aims to improve symptoms caused by fibromyalgia in patients treated with FibrofixPlus®.

Conditions

  • Fibromyalgia

Interventions

DIETARY_SUPPLEMENT

Food supplement

FibrofixPlus® is an authorized food supplement.

Sponsors & Collaborators

  • Arafarma Group, S.A.

    lead INDUSTRY

Principal Investigators

  • Rodríguez Araya, Dr · Hospital Clinic of Barcelona

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-09
Primary Completion
2022-09-06
Completion
2022-11-08

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05718908 on ClinicalTrials.gov